Pfizer Appoints Adobe CEO to Board
Pfizer elected Shantanu Narayen, 50, to serve as a member of the Board. Narayen is president and CEO of Adobe. Prior to his appointment as CEO in 2007, Narayen was Adobe’s president and COO. Previously, he held key product research and development positions within Adobe, including EVP of worldwide products, SVP of worldwide product development, and VP and general manager of the engineering technology group. Before joining Adobe in 1998, he was a co-founder of Pictra, an early pioneer of digital photo sharing over the Internet. Prior to that, he served as director of desktop and collaboration products at Silicon Graphics, and held various senior management positions at Apple Computer.
Berkshire Hathaway Adds Eagle Capital’s General Partner to Board
Berkshire Hathaway named Meryl Witmer, 51, a general partner at Eagle Capital, as Director, as the panel prepares for the eventual departure of Chairman Warren Buffett. From 1989 through the end of 2000, she was one of two General Partners at Buchanan, Parker Asset Management which managed Emerald Partners, an investment partnership.
Qualcomm Appoints Biomedical and Energy Research Heavyweight to Board
Qualcomm, the digital wireless telecom products company, elected Susan Hockfield, Ph.D., 60, to its Board of Directors. Dr. Hockfield served as President of the Massachusetts Institute of Technology (MIT) until July 2012, where she also holds a faculty appointment as Professor of Neuroscience. The first woman and the first life scientist to lead MIT, Dr. Hockfield helped the university break new ground across a range of disciplines. Under her leadership, the university launched the MIT Energy Initiative in 2006, known as MITEI, a $350 million effort to accelerate research, policy and education to achieve a clean energy future.